Correlation Between Merck and Fidelity Blue

Can any of the company-specific risk be diversified away by investing in both Merck and Fidelity Blue at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Fidelity Blue into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Merck Company and Fidelity Blue Chip, you can compare the effects of market volatilities on Merck and Fidelity Blue and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Fidelity Blue. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Fidelity Blue.

Diversification Opportunities for Merck and Fidelity Blue

-0.59

Correlation Coefficient

Merck  Fidelity Blue

Excellent diversification

The 3 months correlation between Merck and Fidelity is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Fidelity Blue Chip in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity Blue Chip and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Fidelity Blue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity Blue Chip has no effect on the direction of Merck i.e., Merck and Fidelity Blue go up and down completely randomly.

Pair Corralation between Merck and Fidelity Blue

Considering the 90-day investment horizon Merck Company is expected to generate 2.45 times more return on investment than Fidelity Blue. However, Merck is 2.45 times more volatile than Fidelity Blue Chip. It trades about 0.22 of its potential returns per unit of risk. Fidelity Blue Chip is currently generating about -0.11 per unit of risk. If you would invest  9,631  in Merck Company on September 16, 2024 and sell it today you would earn a total of  569.00  from holding Merck Company or generate 5.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Merck Company  vs.  Fidelity Blue Chip

Merck Company

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Fidelity Blue Chip

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Fidelity Blue Chip are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable fundamental indicators, Fidelity Blue is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Merck and Fidelity Blue

The main advantage of trading using opposite Merck and Fidelity Blue positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Fidelity Blue can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity Blue will offset losses from the drop in Fidelity Blue's long position.

The idea behind Merck Company and Fidelity Blue Chip pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.